Effective Empiric Antimicrobial Therapy of Bacterial Meningitis and Encephalitis

Diyan Ajeng Rossetyowati; Ika Puspita Sari; Tri Murti Andayani; Titik Nuryastuti

doi:10.30595/pharmacy.v18i2.13257

Effective Empiric Antimicrobial Therapy of Bacterial Meningitis and Encephalitis

Diyan Ajeng Rossetyowati, Ika Puspita Sari, Tri Murti Andayani, Titik Nuryastuti

Abstract

Bacterial meningitis-encephalitis (ME) management therapy is critical to appropriately manage clinical outcomes. This study aims to provide recommendations on appropriate empiric antimicrobial to support the healing period and reduce the risk of disease severity. A cross-sectional study, including inpatients without comorbid diagnosed with bacterial ME, was conducted, and records of antimicrobial prescriptions were obtained. Sociodemographic, clinical (diagnostic), and pharmacological (antimicrobial) variables were assessed. Through multivariate analysis, variables associated with the use of antimicrobials for bacterial infections were identified. A total of 45 patients with ME. The patients, who were from surrounding Center Java and Yogyakarta, had a mean age of 11.27 ± 16.93 years and a male predominance of 56.9% (n = 23). The most frequent bacterial infections were caused by: S. haemolyticus and S. epidermidis (25.93%). A total of 100% the patients (n = 45) received a prescription for empiric antibiotics, predominantly 3^rd generation cephalosporin e.c ceftriaxone (35.56%) and cefotaxime (13.33%). Empiric antimicrobials are frequently prescribed for the first management of bacterial ME, are considered an inappropriate practice due to a lack of clinical benefits, increased generation of antimicrobial resistance, and risk of adverse reactions due to the use of medications that patients do not require. Drug utilization studies are a great tool for monitoring how antimicrobial is being used and planning interventions to improve their use.

Keywords

empiric antimicrobial; meningitis-encephalitis bacterial

References

Al Bekairy, A. M., Al Harbi, S., Alkatheri, A. M., Al Dekhail, S., Al Swaidan, L., & Khalidi, N. (2014). Bacterial meningitis: an updated review. African Journal of Pharmacy and Pharmacology, 8(18), 469-478.

Arditi, M., Mason, E. O., Bradley, J. S., Tan, T. Q., Barson, W. J., Schutze, G. E., ... & Kaplan, S. L. (1998). Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics, 102(5), 1087-1097.

El Bashir, H., Laundy, M., & Booy, R. (2003). Diagnosis and treatment of bacterial meningitis. Archives of disease in childhood, 88(7), 615-620.

Bénard, S., Wright, C., Voisine, J., Olivier, C. W., & Gaudelus, J. (2016). Lifetime cost of meningococcal disease in France: scenarios of severe meningitis and septicemia with purpura fulminans. Journal of infection and public health, 9(3), 339-347.

Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010). Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical microbiology reviews, 23(3), 467-492.

Brown, R. H., & Ropper, A. H. (Eds.). (2005). Adams and victor's principles of Neurology. McGraw-Hill Companies, Incorporated.

Chávez-Bueno, S., & McCracken, G. H. (2005). Bacterial meningitis in children. Pediatric Clinics, 52(3), 795-810.

Fiore, A. E., Moroney, J. F., Farley, M. M., Harrison, L. H., Patterson, J. E., Jorgensen, J. H., ... & Schuchat, A. (2000). Clinical outcomes of meningitis caused by Streptococcus pneumonia in the era of antibiotic resistance. Clinical infectious diseases, 30(1), 71-77.

Japardi, I. (2012). Meningitis Meningococcus. USU digital library.

Karanika, M., Vasilopoulou, V. A., Katsioulis, A. T., Papastergiou, P., Theodoridou, M. N., & Hadjichristodoulou, C. S. (2009). Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry. PloS one, 4(7), e6426.

Khater, W. S., & Elabd, S. H. (2016). Identification of common bacterial pathogens causing meningitis in culture-negative cerebrospinal fluid samples using real-time polymerase chain reaction. International journal of microbiology

Kunze, U. (2014). Tick-borne encephalitis–a notifiable disease, a review after one year: report of the 16th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Ticks and tick-borne diseases, 5(5), 453-456.

Mace, S. E. (2008). Acute bacterial meningitis. Emergency medicine clinics of North America, 26(2), 281-317.

Meisadona, G., Soebroto, A. D., & Estiasari, R. (2015). Diagnosis dan tatalaksana meningitis bakterialis. Cermin Dunia Kedokteran, 42(1), 15-19.

Mitropoulos, I. F., Hermsen, E. D., Schafer, J. A., & Rotschafer, J. C. (2008). Central nervous system infections. Pharmacotherapy: A Pathophysiologic Approach. 7th ed. New York, NY: McGraw-Hill Medical, 1744.

Nau, R., Djukic, M., Spreer, A., & Eiffert, H. (2013). Bacterial meningitis: new therapeutic approaches. Expert review of anti-infective therapy, 11(10), 1079-1095.

Stagni, G. (2004). Handbook of basic pharmacokinetics: Including clinical applications. American Journal of Pharmaceutical Education, 68(1-5), BX1.

Rossoni, A. M. D. O., Dalla Costa, L. M., Berto, D. B., Farah, S. S., Gelain, M., Brandileone, M. C. D. C., ... & Almeida, S. M. D. (2008). Acute bacterial meningitis caused by Streptococcus pneumoniae resistant to the antimicrobial agents and their serotypes. Arquivos de neuro-psiquiatria, 66, 509-515.

Saltman, D. C., Beaman, M. H., & Wesselingh, S. L. (2002). Acute community-acquired meningitis and encephalitis. The Medical Journal of Australia, 177(5), 277-277.

Schentag, J. J. (1991). Correlation of pharmacokinetic parameters to the efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia. Scand. J. Infect. Dis, 74, 218-234.

Scarborough, M., & Thwaites, G. E. (2008). The diagnosis and management of acute bacterial meningitis in resource-poor settings. The Lancet Neurology, 7(7), 637-648.

Shargel, L., Andrew, B. C., & Wu-Pong, S. (1999). Applied biopharmaceutics & pharmacokinetics (Vol. 264). Stamford: Appleton & Lange.

Simon, R. P., Greenberg, D. A., & Aminoff, M. J. (2009). Seizures & Syncope. Clinical Neurology, 7th Ed, New York, McGraw-Hill, 270-291.

Derber, C. J., & Troy, S. B. (2012). Head and neck emergencies: bacterial meningitis, encephalitis, brain abscess, upper airway obstruction, and jugular septic thrombophlebitis. Medical Clinics, 96(6), 1107-1126.

Stockdale, A. J., Weekes, M. P., & Aliyu, S. H. (2011). An audit of acute bacterial meningitis in a large teaching hospital 2005–10. QJM: An International Journal of Medicine, 104(12), 1055-1063.

Straus, S. E., Thorpe, K. E., & Holroyd-Leduc, J. (2006). How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis?. Jama, 296(16), 2012-2022.

Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., ... & Whitley, R. J. (2008). The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical infectious diseases, 303-327.

Van de Beek, D., Brouwer, M. C., Thwaites, G. E., & Tunkel, A. R. (2012). Advances in treatment of bacterial meningitis. The Lancet, 380(9854), 1693-1702.

Viladrich, P. F. (2004). Management of meningitis caused by resistant Streptococcus pneumonia. In Management of Multiple Drug-Resistant Infections (pp. 31-48). Humana Press, Totowa, NJ.

World Health Organization. (1998). Antimicrobial and support therapy for bacterial meningitis in children. In Antimicrobial and support therapy for bacterial meningitis in children (pp. 25-25).

Full Text: PDF

DOI: 10.30595/pharmacy.v18i2.13257

Copyright (c) 2022 PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia)

This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2579-910X